Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
E-mail: | support@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36?Washington?Street |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
Mudanpioside C | C30H32O13 | 172760-03-1 | Details |
Merestinib;LY2801653 | C30H22F2N6O3 | 1206799-15-6 | Details |
3-O-p-Coumaroyloleanolic acid | C39H54O5 | 151334-06-4 | Details |
(Z)-Butylidenephthalide | C12H12O2 | 72917-31-8 | Details |
Shikonofuran A | C18H20O5 | 85022-66-8 | Details |
Magnolol;NSC 293099;5,5'-Diallyl-2,2'-biphenyldiol | C18H18O2 | 528-43-8 | Details |
1,2-Methylenedioxy-3,10,11-trimethoxynoraporphine | C20H21NO5 | 14050-90-9 | Details |
8-Lavandulylkaempferol | C25H26O6 | 883859-83-4 | Details |
Camaldulenic acid | C30H46O4 | 71850-15-2 | Details |
Obtucarbamate A | C11H14N2O4 | 6935-99-5 | Details |
Oxyimperatorin | C16H14O5 | 35740-18-2 | Details |
1''-Methoxyerythrinin C | C21H20O7 | 221002-11-5 | Details |
Fatostatin | C18H18N2S | 125256-00-0 | Details |
Gadobutrol;ZK 135079 | C18H30GdN4O9 | 770691-21-9 | Details |
N6022 | C24H22N4O3 | 1208315-24-5 | Details |
CP-609754 | C29H22ClN3O2 | 1190094-64-4 | Details |
Ronacaleret HCl;SB-751689A;SB 751689;SB751689A;SB-751689;SB 751689A;SB751689 | C25H32ClF2NO4 | 702686-96-2 | Details |
WAY-181187;SAX-187;WAY 181187;WAY181187 | C15H13ClN4O2S2 | 554403-49-5 | Details |
5α-Cholestan-3β-ol;Beta-Cholestanol;Dihydrocholesterol;Zymostanol;NSC 18188;5alpha-Cholestanol;5α-Cholestanol | C27H48O | 80-97-7 | Details |
Mipicoledine;DM-CHOC-PEN;DMCHOCPEN;DM CHOC PEN | C35H48Cl5NO4 | 942149-56-6 | Details |
Elagolix sodium;NBI-56418 sodium | C32H29F5N3NaO5 | 832720-36-2 | Details |
EMD638683 | C18H18F2N2O4 | 1181770-72-8 | Details |
TD-198946;TD198946;TD 198946 | C27H22N4O3S | 364762-86-7 | Details |
ATH686;ATH 686 | C25H28F3N7O2 | 853299-52-2 | Details |
Letermovir;MK-8828;AIC246 | C29H28F4N4O4 | 917389-32-3 | Details |
SC75741 | C29H23N7O2S2 | 913822-46-5 | Details |
Cefpirome sulfate;HR-810 sulfate | C22H24N6O9S3 | 98753-19-6 | Details |
idalopirdine;Lu AE58054 | C20H19F5N2O | 467459-31-0 | Details |
Umeclidinium bromide;GSK573719A | C29H34BrNO2 | 869113-09-7 | Details |
Trametinib (DMSO solvate);Trametinib dimethyl sulfoxide;JTP-74057 (DMSO solvate);GSK-1120212 (DMSO solvate);Trametinib DMSO solvate | C28H29FIN5O5S | 1187431-43-1 | Details |
ENMD-2076 Tartrate;ENMD-2076 L-(+)-Tartaric acid | C21H25N7.x(C4H6O6) | 1291074-87-7 | Details |
(R)-Reticuline | C19H23NO4 | 3968-19-2 | Details |
Gap 26 | C70H107N19O19S | 197250-15-0 | Details |
Darapladib-impurity;Darapladib impurity | C36H38F4N4O2S | 1389264-17-8 | Details |
EPZ004777 | C28H41N7O4 | 1338466-77-5 | Details |
Asunaprevir;BMS-650032 | C35H46ClN5O9S | 630420-16-5 | Details |
Mulberrofuran C | C34H28O9 | 77996-04-4 | Details |
XL413 hydrochloride;XL413;BMS-863233 Hydrochloride;BMS-863233 | C14H13Cl2N3O2 | 1169562-71-3 | Details |
KB-74935;KB74935;KB 74935 | C19H18ClF4N3O3S | 946398-78-3 | Details |
1-Cinnamoylpyrrole | C13H11NO | 252248-89-8 | Details |
2,3-Dihydroisoginkgetin | C32H24O10 | 828923-27-9 | Details |
6,7-Dihydroneridienone A | C21H28O3 | 72959-46-7 | Details |
8-Methyleugenitol | C12H12O4 | 41682-21-7 | Details |
Dodoviscin I | C21H22O7 | 1372527-40-6 | Details |
ent-Labda-8(17),13Z-diene-15,16,19-triol 19-O-glucoside | C26H44O8 | 1245636-01-4 | Details |
Isochamaejasmine | C30H22O10 | 93859-63-3 | Details |
Kadsurin A | C21H24O6 | 99340-07-5 | Details |
Oleuropeic acid 8-O-glucoside | C16H26O8 | 865887-46-3 | Details |
Songoramine | C22H29NO3 | 23179-78-4 | Details |
Gamma-Methoxyisoeugenol | C11H14O3 | 63644-71-3 | Details |
N-Phenethylcinnamamide | C17H17NO | 103188-43-8 | Details |
Cholic Acid;Cholate;Colalin;Cholanic acid | C24H40O5 | 81-25-4 | Details |
Tirasemtiv;CK-2017357 | C12H14N4O | 1005491-05-3 | Details |
Xevinapant;Debio-1143;AT406;SM-406;ARRY-334543 | C32H43N5O4 | 1071992-99-8 | Details |
2,4-Dihydroxy-4,6-dimethoxydihydrochalcone | C17H18O5 | 75679-58-2 | Details |
1,11b-Dihydro-11b-hydroxymedicarpin | C16H16O5 | 210537-04-5 | Details |
Bexagliflozin;EGT1442;THR-1442;EGT0001442 | C24H29ClO7 | 1118567-05-7 | Details |
Ingenol mebutate;Ingenol 3-Angelate;PEP005 | C25H34O6 | 75567-37-2 | Details |
Cussosaponin C | C59H96O25 | 366814-42-8 | Details |
W-15;W15;W 15 | C19H21ClN2O2S | 93100-99-3 | Details |
PF-543;PF 543;PF543;Sphingosine Kinase 1 Inhibitor II | C27H31NO4S | 1415562-82-1 | Details |
(S)-3-AMino-2-Methylpropanoic acid-HCl | C4H10ClNO2 | 925704-45-6 | Details |
VUF 10166 | C13H15ClN4 | 155584-74-0 | Details |
O6-Benzylguanine | C12H11N5O | 19916-73-5 | Details |
Ginsenoside Rg6 | C42H70O12 | 147419-93-0 | Details |
TH9402;TH-9402;TH 9402;Xanthylium | C21H15Br2ClN2O3 | 174230-05-8 | Details |
ARN2966 | C12H12N2O | 102212-26-0 | Details |
CNX-2006;CNX2006;CNX 2006 | C26H27F4N7O2 | 1375465-09-0 | Details |
Episappanol | C16H16O6 | 111254-18-3 | Details |
1,3,5-tris(pyridin-4-ylethynyl)benzene | C27H15N3 | 168289-78-9 | Details |
RRX-001 | C5H6BrN3O5 | 925206-65-1 | Details |
Ilexoside D | C41H66O13 | 109008-27-7 | Details |
Forsythoside E | C20H30O12 | 93675-88-8 | Details |
Delafloxacin meglumine;RX-3341 meglumine;WQ-3034 meglumine;ABT492 meglumine | C25H29ClF3N5O9 | 352458-37-8 | Details |
Vesatolimod;GS-9620 | C22H30N6O2 | 1228585-88-3 | Details |
IKK 16;IKK Inhibitor VII;IKK16;IKK-16 | C28H29N5OS | 873225-46-8 | Details |
Resminostat hydrochloride;RAS2410 hydrochloride;4SC-201 hydrochloride | C16H20ClN3O4S | 1187075-34-8 | Details |
SAR131675;SAR 131675 | C18H22N4O4 | 1433953-83-3 | Details |
IFN-α Receptor Recognition Peptide 1;IRRP1 | C35H59N13O12S | 153840-64-3 | Details |
Psiguadial D | C30H34O5 | 1402066-95-8 | Details |
Borapetoside E | C27H36O11 | 151200-49-6 | Details |
Aglaxiflorin D | C36H42N2O9 | 269739-78-8 | Details |
Denudadione C | C20H20O5 | 61240-34-4 | Details |
3'',4''-Di-O-acetyl-2'',6''-di-O-p-coumaroylastragalin | C43H36O17 | 349545-02-4 | Details |
Ophiopogonanone F | C20H22O7 | 588706-67-6 | Details |
Splendoside | C17H26O11 | 81969-41-7 | Details |
Ethyl p-hydroxyphenyllactate | C11H14O4 | 62517-34-4 | Details |
10-O-Methylprotosappanin B | C17H18O6 | 111830-77-4 | Details |
Diosbulbin L | C19H22O7 | 1236285-87-2 | Details |
Epirengynic acid | C8H14O4 | 1310146-00-9 | Details |
GSK1016790A;GSK101 | C28H32Cl2N4O6S2 | 942206-85-1 | Details |
Carboxin;Vitavax;Kisvax;Carboxine;Carbathiin | C12H13NO2S | 5234-68-4 | Details |
Ganoderic acid D | C30H42O7 | 108340-60-9 | Details |
PF-4989216;PF4989216;PF 4989216 | C18H13FN6OS | 1276553-09-3 | Details |
BX517;BX 517;BX-517;PDK1 inhibitor 2 | C15H14N4O2 | 850717-64-5 | Details |
Tofogliflozin (hydrate);Tofogliflozin hydrate;CSG-452 hydrate | C22H26O6.H2O | 1201913-82-7 | Details |
Acetoxon;AI327526;AI3-27526;AI3 27526;Acetofos | C8H6Cl2N2O3 | 17742-68-6 | Details |
AZD-4818;CCR1 antagonist;AZD4818;AZD 4818 | C27H32Cl2N2O7 | 1003566-93-5 | Details |
Hydroxy-Dynasore;Dyngo-4a | C18H14N2O5 | 1256493-34-1 | Details |
E1210;E 1210;APX001A | C21H18N4O2 | 936339-60-5 | Details |
Product Total: Product Page: | ||||
170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 |